DrugPatentWatch Database Preview
Profile for Russian Federation Patent: 2013120298
US Patent Family Members and Approved Drugs for Russian Federation Patent: 2013120298
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Mar 15, 2032 | Sanofi-aventis Us | ADLYXIN | lixisenatide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |